ARGX

ARGENX SE ARGX

NasdaqLarge CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$2.17M

Quarter to Dec 31

Net income

$1.29B

Quarter to Dec 31

Free cash flow

$679.03M

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$26.11B total
FMR LLC
$4.85B+4.8%
PRICE T ROWE ASSOCIATES INC /MD/
$2.48B-20.6%
Jupiter Topco LLC
$2.30B--
Capital World Investors
$2.04B-2.5%
Artisan Partners Limited Partnership
$1.40B+2.8%
Avoro Capital Advisors LLC
$927.77M0.0%
WELLINGTON MANAGEMENT GROUP LLP
$863.33M-8.9%
BlackRock, Inc.
$721.10M-3.8%
RTW INVESTMENTS, LP
$658.20M0.0%
MORGAN STANLEY
$596.67M+14.7%
Invesco Ltd.
$411.92M-25.3%
BANK OF AMERICA CORP /DE/
$371.33M0.0%
ALLIANCEBERNSTEIN L.P.
$288.93M-6.3%
Bellevue Group AG
$279.26M-3.8%
SANDS CAPITAL MANAGEMENT, LLC
$277.03M-12.3%
BESSEMER GROUP INC
$248.44M+316.8%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
$245.49M-0.5%
SEI INVESTMENTS CO
$236.65M-11.1%
Clearbridge Investments, LLC
$235.45M+9.7%
JENNISON ASSOCIATES LLC
$209.86M-4.7%
FRANKLIN RESOURCES INC
$208.68M-3.7%
CITADEL ADVISORS LLC
$197.07M-3.1%
Pictet Asset Management Holding SA
$183.81M+33.7%
TWO SIGMA INVESTMENTS, LP
$172.23M+70.1%
AMERIPRISE FINANCIAL INC
$168.36M-16.0%
See all 511 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ARGX

Loading ratio trend…

ARGX key financials by period

Reported revenue, net income and operating margin by fiscal year, from ARGENX SE's annual filings on SEC EDGAR.

ARGENX SE reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$2.2M$1.3B—
FY 2024$4.3M$833.0M—
FY 2023$35.5M$-295.1M—
FY 2022$10.0M$-709.6M—
FY 2021$497.3M$-408.3M-70.1%
FY 2020$41.2M$-608.5M—
Source: ARGX filings on SEC EDGAR →

Congress trading in ARGX

1 transaction in ARGX reported by 1 member of Congress under the STOCK Act, most recent trade Jul 10, 2023. Reported transactions, not recommendations.

All Congress stock trades →

About ARGENX SE (ARGX): stock profile, AI score and financials

ARGENX SE (ARGX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ARGX is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), ARGENX SE reports quarterly revenue of $2.2M, net income of $1.3B, free cash flow of $679.0M. Top institutional holders of ARGX by reported 13-F value include FMR, PRICE T ROWE ASSOCIATES, Jupiter Topco, based on the most recent SEC filings. ARGX trades on the Nasdaq exchange and files with the SEC under CIK 1697862. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ARGX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ARGENX SE directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1697862 →